Prognosis of Progressive Cognitive Deficit in Elderly Patients with Mild Cognitive Impairment Receiving Long-Term Treatment (3-year observations)
The aim of the present work was to assess individual prognoses for Cerebrolysin treatment efficacy in mild cognitive impairment syndrome (MCIS) and to identify the most informative tests for prognosticating the development of dementia. A total of 53 patients with the amnestic type of MCIS were treated with Cerebrolysin for three years with regular neuropsychological and psychiatric clinical testing, with analysis of the results by nonparametric statistics, cluster analysis, and linear discriminant analysis. This combination of mathematical methods allowed decreases in cognitive functions to the level of dementia to be predicted. A “risk group” with a rapid decrease in cognitive functions and the threat of dementia was identified,i.e., a group with low therapeutic efficacy. Tests were ranked in terms of their prognostic value.
Keywordsmild cognitive impairment syndrome dementia prognosis statistical methods
Unable to display preview. Download preview PDF.
- 1.S. I. Gavrilova, Ya. B. Fedorova, I. F. Roshchina, and G. I. Korovaitseva, “Prognosis of mild cognitive deficit syndrome, data from a two-year prospective clinical study,” Nevrol. Psikhiat., 107, No. 1, 4–10 (2007).Google Scholar
- 2.S. I. Gavrilova, Ya. B. Fedorova, I. V. Kolykhalov, et al., “The therapeutic potential of Cerebrolysin in the preventative treatment of Alzheimer’s disease,” Nevrol. Psikhiat., No. 8, 24–28 (2008).Google Scholar
- 3.S. I. Gavrilova, I. V. Kolykhalov,Ya. B. Fedorova, et al., “The possibility of preventative treatment of Alzheimer’s disease: results of a 3-year prospective open comparative study of the efficacy and safety of courses of Cerebrolysin and Cavinton in elderly patients with mild cognitive deficit syndrome,” Nevrol. Psikhiat., 110, No. 1, 62–69 (2010).Google Scholar
- 5.S. A. Sudakov, Cluster Analysis in Psychiatry and Clinical Psychology [in Russian], A. S. Tiganov (ed.), MIA, Moscow (2010).Google Scholar
- 6.X. A. Alvarez, V. R. Lonbardi, L. Corzo, et al., “Oral Cerebrolysin enhances brain alpha activity and improves cognitive performance in elderly control subjects,” J. Neural Transm., 59, Supplement 1, 315–328 (2000).Google Scholar
- 17.V. Hachinski, “Cerebral blood flow differentiation of Alzheimer’s disease from multi-infarct dementia,” in: Alzheimer’s Disease: Senile Dementia and Related Disorders, R. Katzman, R. D. Terry, and K. L. Bick (eds.), Raven Press, New York (1978), pp. 97–104.Google Scholar
- 19.E. F. Kaplan, H. Goodglass, and S. Weintraub, The Boston Naming Test, Lea & Febiger, Philadelphia (1983), 2nd ed.Google Scholar
- 20.S. Mattis, “Mental status examination for organic mental syndrome in the elderly patient,” in: Geriatric Psychiatry, L. Bellack and T. B. Karusu (eds.), Grune & Stratton, New York (1976), pp. 77–121.Google Scholar
- 25.B. Reisberg, S. H. Ferris, M. J. de Leon, and T. Crook, “Global Deterioration Scale (GDS),” Psychopharm. Bull., 24, No. 4, 661–663 (1988).Google Scholar
- 27.K. I. Shulman, R. Shedletsky, and I. L. Silver, “The challenge of time: clock-drawing and cognitive function in the elderly,” Int. J. Geriatr. Psychiatr., No. 1, 135–140 (1986).Google Scholar
- 29.D. Wechsler, Wechsler Adult Intelligence Scale – Revised, Psychological Corporation, New York (1981).Google Scholar